Literature DB >> 11459890

Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.

R E Clatterbuck1, C G Eberhart, B J Crain, D Rigamonti.   

Abstract

OBJECTIVES: Cerebral cavernous malformations are linked to mutations of the KRIT1 gene at the CCM1 locus and to mutations at two other loci, CCM2 and CCM3, for which genes are not yet identified. There is little information regarding the function of KRIT1. Histological and immunocytochemical analysis of cavernous malformations have not shed much light on their pathophysiology.
METHODS: Morphological analysis of cavernous malformations was extended to the ultrastructural level by examining lesions from two patients by immunocytochemistry and electron microscopy.
RESULTS: The lesions consisted of endothelial lined vascular sinusoids embedded in a collagen matrix. Nuclei belonging to cells distinct from endothelial cells were rare. The basal lamina of the endothelial cells consisted focally of multiple layers. No tight junctions at endothelial cell interfaces were found; however, several examined endothelial cell interfaces demonstrated apparent gaps between endothelial cell processes where basal lamina was exposed directly to the lumen of the sinusoids. Heavy hemosiderin deposits were found underlying the vascular channels within microns of the basal lamina without evidence of disrupted vessels. No astrocytic foot processes were seen within lesions. Glial fibrillary acidic protein immunocytochemistry confirmed that astrocyte processes stopped at the border of the lesions.
CONCLUSIONS: The absence of blood-brain barrier components may lead to leakage of red blood cells into these lesions and the surrounding brain in the absence of major haemorrhage, thus accounting for the propensity of cavernous malformations to cause seizures. These data also raise the possibility that KRIT1 plays a part in the formation of endothelial cell junctions and expression of a mature vascular phenotype.

Entities:  

Mesh:

Year:  2001        PMID: 11459890      PMCID: PMC1737494          DOI: 10.1136/jnnp.71.2.188

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

Review 1.  Blood-brain barrier biology and methodology.

Authors:  W M Pardridge
Journal:  J Neurovirol       Date:  1999-12       Impact factor: 2.643

2.  Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.

Authors:  J H Wong; I A Awad; J H Kim
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

3.  Mutations in KRIT1 in familial cerebral cavernous malformations.

Authors:  J Zhang; R E Clatterbuck; D Rigamonti; H C Dietz
Journal:  Neurosurgery       Date:  2000-05       Impact factor: 4.654

4.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

5.  The MRI appearance of cavernous malformations (angiomas).

Authors:  D Rigamonti; B P Drayer; P C Johnson; M N Hadley; J Zabramski; R F Spetzler
Journal:  J Neurosurg       Date:  1987-10       Impact factor: 5.115

6.  Correlation of magnetic resonance characteristics and histopathological type of angiographically occult vascular malformations

Authors: 
Journal:  Neurosurgery       Date:  1999-06       Impact factor: 4.654

7.  Cavernous hemangioma of the retina. Immunohistochemical and ultrastructural observations.

Authors:  E Messmer; R L Font; H Laqua; W Höpping; G O Naumann
Journal:  Arch Ophthalmol       Date:  1984-03

8.  Mixed vascular malformations of the brain: clinical and pathogenetic considerations.

Authors:  I A Awad; J R Robinson; S Mohanty; M L Estes
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

9.  Ultrastructural comparison of capillary and cavernous hemangiomas of the orbit.

Authors:  T Iwamoto; F A Jakobiec
Journal:  Arch Ophthalmol       Date:  1979-06

10.  The natural history of familial cavernous malformations: results of an ongoing study.

Authors:  J M Zabramski; T M Wascher; R F Spetzler; B Johnson; J Golfinos; B P Drayer; B Brown; D Rigamonti; G Brown
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

View more
  102 in total

1.  Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions.

Authors:  Anna Raabe; Ann Kristin Schmitz; Katharina Pernhorst; Alexander Grote; Christian von der Brelie; Horst Urbach; Alon Friedman; Albert J Becker; Christian E Elger; Pitt Niehusmann
Journal:  Epilepsia       Date:  2012-03       Impact factor: 5.864

2.  Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice.

Authors:  Aubrey C Chan; Stavros G Drakos; Oscar E Ruiz; Alexandra C H Smith; Christopher C Gibson; Jing Ling; Samuel F Passi; Amber N Stratman; Anastasia Sacharidou; M Patricia Revelo; Allie H Grossmann; Nikolaos A Diakos; George E Davis; Mark M Metzstein; Kevin J Whitehead; Dean Y Li
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

Review 3.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

4.  Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations.

Authors:  Blaine L Hart; Saeid Taheri; Gary A Rosenberg; Leslie A Morrison
Journal:  Transl Stroke Res       Date:  2013-09-21       Impact factor: 6.829

Review 5.  Endogenous endothelial cell signaling systems maintain vascular stability.

Authors:  Nyall R London; Kevin J Whitehead; Dean Y Li
Journal:  Angiogenesis       Date:  2009-01-27       Impact factor: 9.596

6.  PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.

Authors:  Svetlana M Stamatovic; Nikola Sladojevic; Richard F Keep; Anuska V Andjelkovic
Journal:  Acta Neuropathol       Date:  2015-09-18       Impact factor: 17.088

7.  Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Authors:  Angela J Glading; Mark H Ginsberg
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

8.  Differential gene expression in human cerebrovascular malformations.

Authors:  Robert Shenkar; J Paul Elliott; Katrina Diener; Judith Gault; Ling-Jia Hu; Randall J Cohrs; Tzulip Phang; Lawrence Hunter; Robert E Breeze; Issam A Awad
Journal:  Neurosurgery       Date:  2003-02       Impact factor: 4.654

9.  Genetic Screening of Pediatric Cavernous Malformations.

Authors:  Elisa Merello; Marco Pavanello; Alessandro Consales; Samantha Mascelli; Alessandro Raso; Andrea Accogli; Armando Cama; Capra Valeria; Patrizia De Marco
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

10.  Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models.

Authors:  Robert Shenkar; Palamadai N Venkatasubramanian; Alice M Wyrwicz; Jin-cheng Zhao; Changbin Shi; Amy Akers; Douglas A Marchuk; Issam A Awad
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.